8-KLeadership Changes

JOHNSON & JOHNSON 8-K Report, Executive Changes (Nov 22, 2011)

Filed November 22, 2011For Securities:JNJ

Summary

Johnson & Johnson (JNJ) announced a significant leadership transition involving its General Counsel. Russell C. Deyo, the current Vice President and General Counsel, has decided to retire effective March 31, 2012. Mr. Deyo has been a long-standing executive at the company, joining in 1985 and holding key leadership positions including General Counsel since 2004. His departure marks the end of an era for a key legal and executive figure within JNJ. To ensure a smooth transition, Michael H. Ullmann will assume the role of Vice President, General Counsel, and become a member of the Executive Committee starting January 1, 2012. Mr. Ullmann brings extensive experience to the role, having been with Johnson & Johnson since 1989 and most recently serving as General Counsel for the Medical Devices & Diagnostics Group. This leadership change at the General Counsel position is a material event for investors, as this role is critical to the company's legal and strategic operations.

Key Highlights

  • 1Russell C. Deyo, Vice President and General Counsel, announced his retirement, effective March 31, 2012.
  • 2Mr. Deyo has a long tenure with Johnson & Johnson, starting in 1985.
  • 3Michael H. Ullmann appointed as the new Vice President, General Counsel, effective January 1, 2012.
  • 4Mr. Ullmann has been with JNJ since 1989 and has significant experience within the company.
  • 5Mr. Ullmann's most recent role was General Counsel of the Medical Devices & Diagnostics Group.
  • 6Both Mr. Deyo and Mr. Ullmann will be members of the Executive Committee.
  • 7This filing falls under Item 5.02 of Form 8-K, concerning director and officer changes.

Frequently Asked Questions

Russell C. Deyo, Vice President, General Counsel, and a member of the Executive Committee, is retiring. His retirement will be effective March 31, 2012.

Michael H. Ullmann will succeed Mr. Deyo. He will assume the role of Vice President, General Counsel, and become a member of the Executive Committee effective January 1, 2012.

Michael H. Ullmann has been with Johnson & Johnson since 1989. He previously served as Corporate Secretary from 1998 to 2006 and has held the position of General Counsel for the Medical Devices & Diagnostics Group since 2006.

This is a significant leadership change concerning a key executive role. The General Counsel position is vital for managing the company's legal affairs, compliance, and strategic decision-making, making a smooth transition important for business continuity and risk management.